CD19 and B-cell chronic lymphocytic leukemia: Pre-treatment RNAseq data from CD19-enriched peripheral blood samples, i.e. enriched for the CLL cell fraction, were available for 405 of the 432 randomized patients (203 Ven-Obi, 202 Clb-Obi).